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Summary box: “What does this paper contribute to the wider global clinical community?” 
 That by combining two proven methods, motivational interviewing and cognitive 
behavioral therapy, medication adherence may be improved in challenging clinical 
conditions. 
 That a multi-component intervention may be needed to influence medication adherence 
to a prescription regimen in patients with challenging clinical conditions. 
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ABSTRACT  
 
Aims and objectives: The World Health Organization has indicated medication adherence is a 
global problem. Both motivational interviewing (MI) and cognitive behavioral therapy (CBT) 
interventions alone have been found to be effective at improving medication adherence. This 
article summarizes research that has combined motivational interviewing and cognitive 
behavioral therapy to improve medication adherence. 
 
Background: Projections indicate that by 2015, 33% of cancer treatment will be in pill form, 
shifting responsibility for managing medication adherence to patients. These regimens are often 
complex, with multiple doses, drugs, or cycling, and patients often experience side effects from 
symptoms, making adherence difficult. Patients taking cancer treatment in pill form must strictly 
adhere to their regimen to achieve a therapeutically effective level for cancer treatment.  
 
Design: Literature review. 
 
Methods: Data were obtained from six studies that combined MI and CBT in an intervention to 
promote medication adherence. Analysis was performed based on an integrative review process. 
 
Results: Five studies on medication adherence rates using combined MI and CBT reported 
improved medication adherence rates; and one was trending toward improved medication 
adherence rates.  
 
Conclusions: Combined MI/CBT interventions improved medication adherence in various 
conditions; and may be effective in challenging clinical conditions, such as when cancer 
treatment is prescribed in pill form.  
 
Relevance to clinical practice: This review focused on interventions that combined motivational 
interviewing and cognitive behavioral therapy to promote medication adherence. Findings 
provide nurses with an overview of interventions that may be used in developing programs to 
help patients manage adherence to cancer treatment in pill form; as well as in other challenging 
conditions where medication adherence is crucial. A detailed description of the interventions 
found to be effective is provided to assist nurses in translating evidence into practice.  
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INTRODUCTION 
The World Health Organization (2003) had identified medication adherence as a global 
issue, particularly in long-term therapies. For those diagnosed with human immunodeficiency 
virus (HIV), medication adherence is crucial when prescribed long-term antiretroviral therapy 
(ART) (Fogarty et al. 2002). Medication adherence is also crucial for those diagnosed with 
cancer treated in pill form. Projections indicate that within the next few years, a third of cancer 
treatment will be in pill form (Weingart et al. 2008). The therapeutic outcome for those treated in 
pill form depends heavily on the ability to strictly adhere to the prescribed regimen, placing 
greater responsibility on patients. However, patients with cancer are known to miss as much as 
one-third of the prescribed dosage required for treatment of their disease (Spoelstra et al. 2013, 
Spoelstra & Given 2011, Weingart et al. 2008). Medication adherence is more than likely even 
worse for those who have comorbid conditions (Koroukian et al. 2006, Ogle et al. 2000); and the 
majority of cancer patients are older and take multiple medications. Thus, a critical need exists to 
promote adherence in cancer patients being treated in pill form. Known barriers to medication 
adherence in cancer patients  include symptoms from side effects of treatment, low self-efficacy, 
depressive symptoms, beliefs that the medicine will not help, regimen complexity, or lack of 
motivation (Given et al. 2011). Consequently, cancer patients may need a more intensive 
intervention to address the challenging problem of adherence to cancer treatment in pill.  
Combining two proven methods, motivational interviewing (MI) and brief cognitive 
behavioral therapy (CBT), may be a solution to promoting medication adherence in cancer 
patients treated in pill form (Viswanathan et al. 2012a, Viswanathan et al. 2012b). Both MI and 
CBT alone have improved adherence to medications and treatment regimens (Diiorio et al. 2008, 
Donohoe 2006, Holstad et al. 2007, Riekert et al. 2011, Tatrow & Montgomery 2006). MI and 
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CBT have also been combined to improve clinical outcomes in challenging conditions such as 
human immunodeficiency virus (HIV), weight loss in post-surgical bariatric patients, lowering 
hemoglobin A1c in Type-1 diabetes, and reducing anxiety following traumatic brain injury 
(Hsieh et al. 2012, Ismail et al. 2010, Stewart et al. 2010). MI and CBT have also been effective 
at improving difficult behavioral problems such as gambling, or alcohol or drug addiction 
(Greenwald 2002, Hides et al. 2011). In cancer patients prescribed treatment in pill form, CBT 
alone was not found to be effective in improving medication adherence (Spoelstra et al. 2013); 
and we were unable to find studies using MI, or MI combined with CBT, to improve medication 
adherence in cancer patients. Thus, this article examines the evidence to promote medication 
adherence when interventions combine MI and CBT.  
Globally, healthcare environments are fast-paced and often burdened by the number of 
patients seeking care. Consequently, nurses are challenged to focus on medication adherence. 
Nor have we identified evidence-based practice standards that promote medication adherence. 
We need to improve the ability of nurses to help patients achieve medication adherence. 
BACKGROUND 
In general, a review of 50 years of research across diseases found a medication adherence 
rate of 74.5% (DiMatteo et al. 2002). A recent review of studies on those with cancer treatment 
in pill form found medication adherence rates varied widely, ranging from 16% to 80% 
(Spoelstra & Given 2011). In our prior study on oral cancer treatment, we found a 67% rate of 
adherence (Spoelstra et al. 2013). In addition, Streeter and colleagues (2011) found 10% of 
patients newly prescribed oral agents stopped taking their medication in the first month. As a 
result of poor adherence to cancer treatment in pill form, patients may face treatment failure, 
hospitalization, and, in some instances, nonadherence may even influence longevity (Given et al. 
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2011, Spoelstra & Given 2011). Medication adherence is a significant clinical problem for those 
prescribed cancer treatment in pill form, which may compromise the ability of the medication to 
treat the cancer.  
Interventions to Promote Medication Adherence  
 Research has not conclusively identified interventions that are effective at promoting 
medication adherence (Conn et al. 2009, Ruppar et al. 2008). Nonetheless, in a literature review 
of 64 medication adherence interventions, three types were found to be somewhat effective 
(Ruppar et al. 2008). This included knowledge through patient education (PE); motivation 
through use of MI; and behavior modification through use of CBT. Contrary to other evidence, a 
Cochrane review of 19 medication adherence studies (n = 2159) in HIV patients suggests that 
interventions directly targeting practical medication management skills tend to be more effective 
at improving adherence than those targeting psychological constructs (e.g., self-efficacy, 
attitudes, motivation) (Rueda et al. 2006). However, this review did not evaluate interventions 
that combined CBT and MI to promote medication adherence. 
Cognitive Behavioral Therapy (CBT) for Promoting Medication Adherence 
 CBT is a short-term, goal-oriented, psychotherapeutic approach that is based on the idea 
that thoughts cause feelings, and consequently, behaviors (Lambert et al. 2004). CBT can be 
thought of as a combination of psychological and behavioral therapy that includes assessment, 
reconceptualization, and skill acquisition and application. The psychotherapy component 
emphasizes the importance of the personal meaning we place on things and how thinking 
patterns begin in childhood. The behavioral therapy component pays close attention to the 
relationship between our problems, our behavior, and our thoughts. CBT is based on the theory 
that the events do not upset a person, but the meanings given to the thoughts about the event, 
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which can block behaviors such as medication taking (e.g., not believing the pills will help cure 
the cancer). If thoughts are too negative, it can block taking action, as a patient continues to hold 
onto the old thoughts and fails to learn new behaviors (e.g., prescription is not refilled and pills 
are not taken as prescribed). 
 In a review of 64 medication adherence intervention studies, 48% of the studies using 
CBT found improvement in medication adherence, with most using face-to-face interactions 
(Ruppar et al. 2008). A meta-analysis of 33 trials on interventions designed to improve 
medication adherence, found an Effect Size (ES) of .33 for brief CBT (Conn et al. 2009). The 
majority of these CBT interventions were 15-minute face-to-face interactions targeting self-
administration which was then supplemented with written instructions.  In addition, the meta-
analysis found that standardized interventions were more effective than those that were tailored.  
 Regarding cancer treatment in pill form, there is some evidence of pharmacist- and nurse-
led home-based programs to improve medication adherence using CBT. In one pharmacist-led 
program, initial patient contact was within 24 hours of the prescription being written; and CBT 
was used to review the regimen schedule, side effects, safe handling, drug-to-drug interactions, 
how to fill and refill prescription, and a referral was provided for co-pay assistance or free drugs 
(Khandelwal et al. 2011). The program also conducted weekly phone calls to patients during the 
first cycle of the oral agent to assess adherence and symptoms; and to conduct further CBT. In 
another pharmacist-led program, an evaluation of the oral agent prescription occurred for 
appropriateness in terms of dose and indication, labs were checked if appropriate, drug 
interactions were reviewed, and financial issues resolved (Mancini et al. 2011). CBT was 
provided by the pharmacist, with weekly follow-up of adherence and provision of strategies for 
symptom management. An oncologist followed-up for treatment efficacy, if needed. In the 
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nurse-pharmacist–led clinic to promote adherence to capecitabine, they focused on metastatic 
colorectal cancer patients (MacLeod et al. 2007). The primary function of the clinic was to 
provide CBT for early detection and management of treatment of side effects; and for the 
clinicians to oversee management of any treatment-related events. Emphasis was placed on the 
patient’s ability to recognize grade 2 toxicities during therapy to reduce the occurrence of serious 
adverse events. However, none of these 3 programs reported medication adherence rates, making 
it difficult to determine their effectiveness.  
 While some experts assert that CBT may be a requisite for medication adherence, it is 
often not sufficient (Haynes et al. 2005). In our prior study on adherence to cancer treatment in 
pill form, CBT alone did not promote a difference in adherence rates (Spoelstra et al. 2013). 
Further, others have reported that a major barrier to adherence involves motivation (Possidente et 
al. 2005). Adding a motivational approach like MI (Diiorio et al. 2008), in addition to CBT, may 
be needed to promote medication adherence in challenging clinical conditions such as with 
cancer patients who receive treatment in pill form.  
Motivational Interviewing (MI) for Promoting Adherence 
 Of all approaches to transforming patient reluctance to change, one of the most influential 
has been the concept of MI. A large body of literature indicates that MI is effective for both 
cessation of harmful behaviors and for adoption of healthy behaviors (Gance-Cleveland 2007, 
Rubak et al. 2005).  There are studies using MI to increase awareness and provide education to 
promote medication adherence, with an effect size (ES) ranging from .22 to .67. This includes 
patients with asthma (Riekert et al. 2011), HIV (Diiorio et al. 2008, Ingersoll et al. 2011), 
osteoporosis (Solomon et al. 2012), epilepsy (DiIorio et al. 2009), and cardiovascular disease 
(Johnson et al. 2006a, Johnson et al. 2006b, Lawrence et al. 2008). One HIV study (n  = 45) that 
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used semi-structured hour-long face-to-face MI sessions for 6 weeks followed by six biweekly 
face-to-face MI sessions focused on skill-building (Ingersoll et al. 2011). Two large trials (n = 
404; 1,227) using MI for patients on lipid-lowering drugs and hypertensive drugs reported 
sustained improvement in medication adherence rates with mailed information (Johnson et al. 
2006a, Johnson et al. 2006b). In contrast, a large trial of 2,087 participants that used MI via the 
phone to promote adherence to osteoporosis medication did not find improvement. However, this 
study did not use face-to-face contacts nor did it intervene when the prescription was initiated 
(Solomon et al. 2012). A major gap is that no MI interventions were found promoting 
medication adherence in cancer patients taking oral agents.  
Combining Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT)  
Several studies combined MI and CBT and are available in the literature. Most focus on 
behavioral issues (e.g., alcoholism or gambling) and are reported elsewhere. We focused on 
evidence that combined MI—CBT in clinical conditions. 
A randomized control trial in Type-1 diabetes patients examined the affect of a combined 
MI with CBT intervention on glycemic control in 344 adults (mean age 26 years [range 18 to 
65]; 60% female) (Ismail et al. 2010). Patients had a starting glycosylated hemoglobin (HbA1c) 
value between 8.2—15%. The intervention was delivered by Registered Nurses (RNs) in 12 
face-to-face sessions over 6-months. Findings indicate the 12-month HbA1c was .45 
(Confidence Interval [CI] .15 to .79; p = 0.008) lower in the combined MI—CBT group 
compared to usual care; and .16 (CI .20 to .51; p = 0.38) lower for MI alone compared to usual 
care.  
A second randomized control trial on anxiety following moderate to severe traumatic 
brain injury included 27 patients (age 21 to 73; 78% male) and compared a combined MI—CBT 
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intervention to reduce anxiety to CBT alone and to usual care (Hsieh et al. 2012). The combined 
MI—CBT intervention was delivered in 12 1-hour individualized face-to-face sessions. 
Although CBT is the treatment of choice for traumatic brain injury, participants receiving MI 
showed greater response to CBT in terms of reducing anxiety, stress, and unproductive coping, 
compared with participants who received CBT alone or usual care (p < .01). 
 A cohort study combined CBT and MI to intervene on weight loss in 14 female bariatric 
patients (ages 32 to 67; 72% Caucasian and 28% African American) and followed them post-
surgically for 18 months (Stewart et al. 2010). The intervention included 8-weekly small group 
sessions, each lasting 90 minutes long delivered by doctoral students supervised by faculty. Each 
session consisted of a specific topic for education and discussion as well as unstructured time for 
open discussion. Homework was assigned specific to individual goals. Findings indicated a mean 
weight loss of 4-pounds (range 0 to 6). 
 In these three studies (total n = 385) combining MI—CBT, there were 12 sessions over 
2—6 months with each session lasting 50–120 minutes either individually or in a group. 
Interventionists were trained psychology doctoral students or RNs. Sessions included 
emphasizing the interconnected nature of thoughts, feelings, and behaviors; agenda-setting, 
homework, and feedback focused on diet, exercise, lifestyle behaviors, anxiety, worry, stress 
management, negative thoughts, impulse control, activities, and assertiveness training; and 
learning to consolidate gains to future situations. In regard to change, sessions included behavior 
change, acceptance, and coping flexibility; strategies to enhance readiness for change; level of 
importance, confidence, and readiness to change; a change plan tailored to individuals’ needs 
and level of motivation; and endorsement of reasons to change. MI combined with CBT 
significantly improved outcomes of these challenging health conditions. 
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AIMS 
 This literature review addresses a gap in the literature by identifying interventions that 
combine MI and CBT to promote medication adherence, and describing these interventions in 
detail so that nurses may utilize this information in clinical practice. The ultimate goal was to 
provide a scientific basis for the development of an intervention to promote adherence in the 
increasing number of cancer patients being treated in pill form. To date, evidence supports that 
MI and CBT individually improve medication adherence; and improve health outcomes in some 
challenging clinical conditions. Therefore, examining the literature on combining MI and CBT to 
target medication adherence may lead to ways of helping nurses improve medication adherence 
in cancer patients treated in pill form. The objectives were as follows. (1) To generate a list of 
combined MI—CBT interventions to promote medication adherence. (2) To determine the 
effectiveness of the combined MI—CBT intervention on medication adherence rates. (3) To 
describe the components, mode of delivery, and dose of the intervention that addressed 
medication adherence. 
METHODS 
Study design: Integrative review 
A integrative review method informed by Whittenmore and Knafl (2005) was adopted for 
this review. An integrative review is a comprehensive process that involves data collection and 
extraction of data, which leads to evidence suitable for use in clinical practice. Identifying 
relevant studies for this article was performed in two steps. First, a search of electronic databases 
for pertinent articles published over the past 10 years. Second, the reference lists were searched 
for additional relevant studies.  
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Inclusion/exclusion criteria 
To address the above objectives, research articles reporting on the evaluation of 
interventions meeting the preset inclusion criteria were selected for this review. The criteria 
included: 
     (1) English-language articles published from 2005 to 2014. 
     (2) An intervention combining MI and CBT to affect a behavioral change to promote  
medication adherence. 
Exclusion criteria included the following: 
(1) An intervention not within the scope of nursing practice that could not be 
implemented without a medical order. 
 (2) Articles not reporting the influence of the intervention on the rates of adherence. 
(3) Studies reporting on non-experimental research studies were excluded; as such 
designs are limited in generating evidence to determine effective interventions. 
Search strategies 
Using the integrative review steps, we identified our problem, examined the existing 
literature on articles that combined MI and CBT in interventions to promote medication 
adherence, conducted an evaluation of the findings in each article, and summarized the findings 
for this article. First, a search in Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) and PubMed for peer reviewed research articles published between 2005 and 2014. 
Keywords were “motivational interviewing”; “cognitive behavioral therapy”; “intervention”, and 
“medication adherence.”  Second, the reference lists of those articles were reviewed for other 
relevant articles.  
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Data extraction and analysis 
Data were extracted on study characteristics, intervention characteristics, and results 
pertaining to the effects of the MI—CBT intervention on medication adherence rates. Data 
extraction was performed by four reviewers. The first two independently read the articles, 
carefully documenting relevant information in a table; the other two reviewed the study reports 
and confirmed the accuracy of the information. This iterative process continued until consensus 
was reached on the articles meeting the inclusion criteria included in this review.  
Literature search 
As shown in the Figure, 2,822 articles were retrieved on “MI” and 48,566 articles were 
retrieved on “CBT”.  We narrowed those groups to English language within the past 10 years. 
The terms “MI and CBT” combined yielded 206 articles. When the term “intervention” was 
added, 100 articles were found. These 100 articles were examined by four reviewers using the 
inclusion criteria until consensus was reached on which articles to retain in this review through 
an iterative process. Six articles were identified as using combined MI—CBT interventions to 
improve medication adherence, fitting the inclusion criteria. 
RESULTS 
Study characteristics 
As shown in Table 1, the studies included in this review were published between 2005 
and 2011. This included a randomized controlled trial (RCT); four cohort studies; and one case 
study. The setting in which the intervention under investigation was implemented was 
consistently in patients’ homes.  
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Participant characteristics 
Total sample size ranged from one to 402 across studies, with a total of 845 subjects in 
the six studies. Participant ages varied between 17 and 94, with an overall mean of 47.9 years. 
The mean percentage of female participants was 75.3% (range 40—100%). Race was not 
consistently reported. Interventions targeted different types of medications, thus, different 
populations.  
Intervention characteristics 
The RCT (n = 15; mean age 44; 94% male) was conducted by a therapist with a master’s 
degree in psychology who had training in MI and CBT (Parsons et al. 2005). The intervention 
consisted of individual face-to-face sessions held once-per-week for 1-hour, for 8-weeks; with 
follow-up by phone for 3-months. Seventy-three percent completed all 8-weekly sessions; with 
80% retention over 3-months. The first session was conducted immediately after the baseline 
interview. Sessions one and two explored ambivalence and building confidence for medication-
taking, with feedback to enhance confidence and set goals. The third focused on triggers leading 
to missing medications. Sessions 4—7 used functional analysis to build content to meet 
individual needs (see Table 2). The last session focused on acquired skills and future goals. 
Patients were given self-monitoring cards to track medication adherence. Follow-up calls 
monitored adherence and attainment of goals.  
The next four studies addressed cognitive and emotional reactions as suggested by 
Leventhal’s theory (1999), using MI (Miller & Rollnick 2002) to reduce ambivalence about 
treatment and CBT (Beck 2000) to address negative beliefs about treatment. Prochaska’s (1994) 
model of readiness to change was to assess ability to adopt medication taking behaviors. Each 
study conducted an assessment on the first call using an algorithm of factors that included prior 
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adherence, social support, and treatment complexity, to identify patients at-risk or low-risk for 
nonadherence (Cook 2006) to determine intervention dose. 
The osteoarthritis study (n = 402; mean age of 66.9; 94% female) intervened with RNs 
(4) by phone (Cook et al. 2007). Of those in the study, 79% (n = 317) were new to treatment; 5% 
(n = 30) were a mean of 13.3 days into treatment; and 15% (n = 65) had not started. RNs 
initiated contact within 14-days of medication start date, and followed patients for a mean of 4.1 
(range 0—14) months. On the first call, 64.7% (n = 260) were determined to be at-risk for 
nonadherence and 35.3% (n =142) were low-risk. At-risk received 5-calls (range 3—8); and low-
risk received 3-calls (range 2—8). On average, calls lasted 15.3 minutes. RNs asked whether or 
not patients had started treatment and if currently adherent. If had not started, or stopped but still 
wanted treatment, calls focused on relationship building and answering questions to build the 
motivation for treatment. If started treatment but was having difficulty remaining adherent or had 
questions about the medication, calls focused on problem-solving and support to address 
patients’ concerns. The goal was to resolve barriers to adherence, and increase self-efficacy and 
motivation for medication adherence. RNs helped patients practice skills to self-manage 
medication taking behaviors. 
The ulcerative colitis study (n = 278; mean age 49; 66% female) intervened via RNs by 
phone, and the intervention was provided by the same RN over the course of the study (Cook et 
al. 2010). RNs had prior work experience in mental health; and attended an eight hour training 
session, received 3-hours of individual training, and attended weekly team meetings for 
feedback. Seventy-three percent (n = 203) were at-risk for medication nonadherence. RNs 
initiated contact within 1 day of the medication start date; and followed patients for a mean of 6 
months (standard deviation [SD] = 1.35). On average, patients received 4.2 calls (SD = 2.55); 
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with an average length of call 13.5 minutes (SD = 4.42). Pre-determined scripts were used for the 
calls. Notably, the intervention was based on patient concerns about readiness to change, 
addressing both cognitive and emotional reactions rather than simply delivering information. For 
example, MI questions to reduce ambivalence about treatment and CBT to address negative 
beliefs about treatment or to cope with adverse events. 
The antipsychotic study (n = 51; mean age 33; 86% female) intervened with three RNs on 
the phone, each working with the same patient over time (Cook et al. 2008). Participants were 
members of a managed care plan, new to treatment, and prescribed the medication within the 
past 30-days. Ninety percent (n = 46) of the participants were screened at-risk for nonadherence. 
At-risk had a mean of 7.2 call attempts; with mean of 3.5 completed over an average of 4.4 
months. Average call length was 11 minutes. Total contact time on average per participant was 
38.5 minutes. Low-risk for nonadherence received a toll-free number plus 1-call at 6-months. 
During each call, the RN intervened based on the participant readiness for change and individual 
barriers to adherence. RNs also mailed follow-up written materials to 45 (88%) participants.  A 
written progress note was sent to the patients’ health plan case manager after each call. 
Participants did not receive incentives. Four participants reported potential serious adverse drug 
events; and were referred to their primary care provider.  
The HIV study (n = 98; mean age 44; 67% male) intervened with 10 RNs by phone, with 
each participant assigned to the same RN (Cook et al. 2009). Ninety-two percent (n = 90) were 
new to ART treatment. Those with low-risk for nonadherence only received 1-call at 6 months. 
Those at-risk for nonadherence received, on average, 3.0 calls (range 1—14). Average call 
length was 5-minutes (SD 11.7). No standardized script was utilized. The goal was to motivate 
patient adherence to ART treatment. Emphasis was placed on training RNs to focus on patients 
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concerns rather than providing information. Information that was provided was not standardized, 
but in response to the patients requests and needs.  
The case study (n = 1; age 17; female) was conducted by a trained therapist (Hilliard et 
al. 2011). The intervention included 35-sessions of MI and CBT. The initial assessment was 
conducted face to face, and an electronic pill bottle to measure adherence was provided. The 
intervention content is listed in Table 2. Caregivers (parent and sister) were involved throughout 
the intervention. 
Measures of Medication Adherence 
Three means of medication adherence were identified (see Table 1). The RCT study 
measured adherence by self-report. In the cohort studies, adherence was measured by self-report 
and pharmacy fill records. In the case study, an electronic pill bottle was provided to measure 
adherence.  
Intervention Effect on Medication Adherence 
In the RCT, seven participants (46.6%) reported missing at least 1-dose in the prior 2-
weeks; five (33%) reported a missed dose in the past 2-days and 2-missed (13.3%) doses within 
the past 24-hours (Parsons et al. 2005). Three-month follow-up found 4-participants (33%) 
reported missing a dose during the past 2-weeks; one (8.8%) missing a dose over the past 2-days; 
and none missing a dose within 24-hours. Post-treatment reasons given for missing medication 
included fear of stigma (n = 1) and running out of the medication (n = 1). Thus, in the RCT, 
pretreatment number of missed medication doses in the last 14 days was 5.58 compared to 0.92 
post treatment, “trending” toward significance.  
In the cohort studies, intervention ES was established. This was done by comparing the 
study group to national reference data. 
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 In the osteoarthritis study, adherence was higher than the population base rate after 3-
months (X 2 = 7.32; p = .007) and 6-months (X 2 = 6.75; p = .009) (Cook et al. 2007). Average 
ES of the intervention was 0.19 across time periods (3 and 6 months).  A comparison was 
conducted between the intervention group and those referred but not participating at 6-months 
with the intervention group at 69% adherence, and referred not participating at 63%, approaching 
significance (X 2 = 20.34; p = .06) with a moderate ES of .33.  
In the ulcerative colitis study, 4-participants did not start treatment; and three (75%) 
agreed to start after speaking with the RN (Cook et al. 2010). Nineteen (7%) reported stopping at 
any point in time; and 10 of 19 (53%) agreed to resume. Overall, 6-month adherence was higher 
than the population norm (X 2 = 2.22; p < .001). The ES of the intervention was .35. Patient 
reasons reported for nonadherence included cost of treatment, treatment logistics, forgetting, 
thinking the medication is not needed, being too sick to take the medication, and having concerns 
regarding adverse events.   
In the anti-psychotic study, pharmacy fill rates for intervention group was 59% (n = 29) 
for 3-consecutive months; and 48% for 6-months, significantly higher than population base (X 2 
= 8.02; p = .004) (Cook et al. 2008). For self-report, five (9.8%) did not fill the initial script 
and18 (38.9%) stopped treatment at some points. Three (of 5; 60%) who did not start and seven 
(of 18; 38.9%) who stopped agreed to resume treatment after receiving the intervention. Six-
month adherence was 50%, higher than the population base (X 2 = 9.47; p = .002). ES of 
intervention at 6 months on medication adherence was .22.  
In the HIV study, 59% (n = 29) received at least three consecutive months of medication, 
and 48% were adherent for 6-months, a higher rate than the comparison group (X 2 = 8.01; p = 
.004) (Cook et al. 2009). Self-reported adherence found five (9.8%) participants did not fill an 
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initial prescription and 18 (35.3%) stopped treatment at some point. Three of five (60%) who did 
not start and seven of 18 (38.9%) who stopped agreed to resumed treatment after speaking with 
the RN. Six month adherence was 50%, higher than population base (X 2 = 9.47; p = .002). Thus, 
ES of .25 for receipt of script; and .25 for 95% adherence to the medication. 
One study used an electronic monitoring device to measure adherence (Hilliard et al. 
2011). Pretreatment adherence rate in the case study was 25%, compared to post treatment 
medication adherence of 77% (p < .01) on average; and medication adherence 82% (p < .01) at 
the final session in the intervention.  
DISCUSSION 
Most of the interventions on medication adherence studies that combined MI—CBT 
included an assessment risk of nonadherence using an algorithm to include prior adherence, 
social support, and treatment complexity to predict at-risk versus low-risk; and provided 
intervention dose accordingly. Both intensive face-to-face and brief calls were effective at 
promoting medication adherence. Interventionists were RNs or a therapist, with MI and CBT 
training. Initiation of the interventions occurred on days 1, 14, and 60 after the prescription was 
written, with greater improvement in medication adherence with those timed closer to the date of 
initiation of treatment (prescription). The content of interventions was consistent, most focusing 
on readiness for change, reducing ambivalence, problem solving, coping, goal setting, dealing 
with adverse events, and reviewing acquired medication taking behaviors/skills. The majority 
tailored to the individual’s needs, providing interactions and written materials specific to that 
person, such as MI questions to reduce ambivalence about treatment and CBT to address 
negative beliefs about treatment or to cope with adverse events. In addition, one study provided 
a self-monitoring card to track medication adherence. Five of six studies demonstrated a 
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significant improvement in medication adherence with ES for face-to-face sessions of .52 and 
calls ranging from .19 to .35. The sixth study was “trending” toward significance.   
Strengths of this review included consistency among intervention approaches; and sample 
size. Limitations of this review include the strength of the studies, with only one RCT.  
CONCLUSION 
These findings indicate an intervention with MI—CBT combined may be an effective 
method for eliciting behavior change and promoting medication adherence. The use of MI, in 
combination with CBT, may better address patients at their level of readiness to change and 
places responsibility to change on the person. Combined MI—CBT might be a means of 
improving medication adherence in challenging clinical conditions, such as in cancer patients 
prescribed treatment in pill form. With so much at stake for patients prescribed treatment in pill 
form, medication adherence is critical, and more complex interventions may be needed.   
RELEVANCE TO CLINICAL PRACTICE 
Multiple strategies are needed to improve medication adherence, especially for cancer 
patients treated in pill form, to ensure the best possible outcome. MI and CBT are commonly 
used interventions that can be combined to treat complex clinical issues like medication 
adherence. Intervening on factors such as motivation, self-efficacy, emotions, and beliefs using a 
combined MI—CBT approach may improve adherence to oral agents. MI and CBT may be 
relatively simple to implement, by modifying how nurses talk to patients. Examples of talking 
points are provided in Table 3. A MI—CBT intervention has the potential to impact other 
chronic diseases, promoting adherence to treatment regimens. 
 
 
20 
 
 
 
 
 
 
21 
 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
 
 
 
 
 
 
 
24 
 
 
References 
Beck J (2000) Improving medication compliance with cognitive techniques. Open Minds Advisor 
2, 1-3. 
Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR & Russell CL (2009) Interventions to 
improve medication adherence among older adults: meta-analysis of adherence outcomes 
among randomized controlled trials. Gerontologist 49, 447-462.  
Cook PF (2006) Promoting treatment adherence: a practical handbook for health care 
providers. Thousand Oaks, CA. 
Cook PF, Emiliozzi S, El-Hajj D & McCabe MM (2010) Telephone nurse counseling for 
medication adherence in ulcerative colitis: A preliminary study. Patient Education and 
Counseling 81, 182-186.  
Cook PF, Emiliozzi S & McCabe MM (2007) Telephone Counseling to Improve Osteoporosis 
Treatment Adherence: An Effectiveness Study in Community Practice Settings. 
American Journal of Medical Quality 22, 445-456.  
Cook PF, Emiliozzi S, Waters C & El Hajj D (2008) Effects of telephone counseling on 
antipsychotic adherence and emergency department utilization. American Journal of 
Managed Care 14, 841-846. 
Cook PF, McCabe MM, Emiliozzi S & Pointer L (2009) Telephone Nurse Counseling Improves 
HIV Medication Adherence: An Effectiveness Study. Journal of the Association of 
Nurses in AIDS Care 20, 316-325.  
DiIorio C, Escoffery C, Yeager KA, McCarty F, Henry TR, Koganti A, Reisinger E, Robinson E, 
Kobau R & Price P (2009) WebEase: development of a Web-based epilepsy self-
management intervention. Preventing Chronic Disease 6, A28. 
Diiorio C, McCarty F, Resnicow K, Holstad MM, Soet J, Yeager K, Sharma SM, Morisky DE & 
Lundberg B (2008) Using motivational interviewing to promote adherence to 
antiretroviral medications: a randomized controlled study. AIDS Care 20, 273-283.  
DiMatteo MR, Giordani PJ, Lepper HS & Croghan TW (2002) Patient adherence and medical 
treatment outcomes: A meta-analysis. Medical Care 40, 794-811. 
Donohoe G (2006) Adherence to antipsychotic treatment in schizophrenia: what role does 
cognitive behavioral therapy play in improving outcomes? Disease Management & 
Health Outcomes 14, 207-214.  
Fogarty L, Roter D, Larson S, Burke J, Gillespie J & Levy R (2002) Patient adherence to HIV 
medication regimens: a review of published and abstract reports. Patient Education and 
Counseling 46, 93-108.  
Gance-Cleveland B (2007) Motivational interviewing: improving patient education. Journal of 
Pediatric Healthcare 21, 81-88.  
Given BA, Spoelstra SL & Grant M (2011) The challenges of oral agents as antineoplastic 
treatments. In Seminars in Oncology Nursing. Elsevier, pp. 93-103.  
Greenwald R (2002) Motivation-adaptive-skills-trauma resolution (MASTR) therapy for 
adolecents with conduct problems: an open trial. Journal of Agression, Maltreatment, & 
Trauma 6, 237-261.  
25 
Haynes RB, Yao X, Degani A, Kripalani S, Garg A & McDonald HP (2005) Interventions to 
enhance medication adherence. Cochrane Database of Systematic Reviews, CD000011.  
Hides LM, Elkins KS, Scaffidi A, Cotton SM, Carroll S & Lubman DI (2011) Does the addition 
of integrated cognitive behaviour therapy and motivational interviewing improve the 
outcomes of standard care for young people with comorbid depression and substance 
misuse? Medical Journal of Australia 195, S31-37. 
Hilliard ME, Ramey C, Rohan JM, Drotar D & Cortina S (2011) Electronic monitoring feedback 
to promote adherence in an adolescent with fanconi anemia. Health Psychology 30, 503-
509.  
Holstad MM, Dilorio C & Magowe MK (2007) Motivating HIV positive women to adhere to 
antiretorviral therapy and risk reduction behavior: the KHARMA project. Online Journal 
of Issues in Nursing 11, 18p. 
Hsieh M-Y, Ponsford J, Wong D, Schönberger M, Taffe J & Mckay A (2012) Motivational 
interviewing and cognitive behaviour therapy for anxiety following traumatic brain 
injury: A pilot randomised controlled trial. Neuropsychological rehabilitation 22, 585-
608.  
Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, Heckman CJ, Ceperich SD, Hettema J & 
Marzani-Nissen G (2011) A pilot randomized clinical trial of two medication adherence 
and drug use interventions for HIV+ crack cocaine users. Drug and Alcohol Dependence 
116, 177-187.  
Ismail K, Maissi E, Thomas S, Chalder T, Schmidt U, Bartlett J, Patel A, Dickens C, Creed F & 
Treasure J (2010) A randomised controlled trial of cognitive behaviour therapy and 
motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-
optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. 
Health Technoogyl Assessment 14, 1-101, iii-iv. 
Johnson SS, Driskell M, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM & Bourne L 
(2006a) Transtheoretical model intervention for adherence to lipid-lowering drugs. 
Disease Management 9, 102-114.  
Johnson SS, Driskell M, Johnson JL, Prochaska JM, Zwick W & Prochaska JO (2006b) Efficacy 
of a transtheoretical model-based expert system for antihypertensive adherence. Disease 
Management 9, 291-301.  
Khandelwal N, Duncan I, Ahmed T, Rubinstein E & Pegus C (2011) Impact of clinical oral 
chemotherapy program on wastage and hospitalizations. Journal of Oncology Practice 7, 
e25s-e29s.  
Koroukian SM, Murray P & Madigan E (2006) Comorbidity, disability, and geriatric syndromes 
in elderly cancer patients receiving home health care. Journal of Clinical Onclogy 24, 
2304-2310.  
Lambert MJ, Bergin AE & Garfield SL (2004) Introduction and historical overview. In 
Handbook of Psychotherapy and Behavior Change, 5th edn (Sons JW ed.), New York, 
pp. 3-15. 
Lawrence DB, Allison W, Chen JC & Demand M (2008) Improving medication adherence with 
a targeted, technology-driven disease management intervention. Disease Management 11, 
141-144. 
Levanthal EA, Leventhal H, Robitaile C & Brownlee S (1999) Psychosocial factors in 
medication adherence: A model of the modeler. In D. C. Park, R. W. Morrell, & K. 
26 
Shifren (Eds.). Processing of Medical Information in Aging Patients (pp. 145-166)/ 
Mahwah, NJ: Lawrence Erlbaum. 
MacLeod A, Branch A, Cassidy J, McDonald A, Mohammed N & MacDonald L (2007) A 
nurse/pharmacy led capecitabine clinic for colorectal cancer: results of a prospective 
audit and retrospective survey of patient experiences. European Journal of Oncology 
Nursing 11, 247-254.  
Mancini R, Kaster L & Vu B (2011) Implementation of a pharmacist-managed interdisciplinary 
oral chemotherapy program in a community cancer center. Journal of Hematology 
Oncology Pharmacy 1, 23-30. 
Miller WR & Rollnick S (2002) Motivational interviewing: Preparing people for change. 
Guilford press. 
Ogle KS, Swanson GM, Woods N & Azzouz F (2000) Cancer and comorbidity. Cancer 88, 653-
633.  
Parsons JT, Rosof E, Punzalan JC & Di Maria L (2005) Integration of motivational interviewing 
and cognitive behavioral therapy to improve HIV medication adherence and reduce 
substance use among HIV-positive men and women: results of a pilot project. AIDS 
Patient Care & STDs 19, 31-39. 
Possidente CJ, Bucci KK & McClain WJ (2005) Motivational interviewing: A tool to improve 
medication adherence? American Journal of Health-System Pharmacy 62, 1311-1314. 
Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, FioRe C, 
Harlow LL, Redding CA, Rosenbloom D & Rossi SR (1994) Stages of change and 
decisional balance for 12 problem behaviors. Health Psychology 13, 39-46.  
Riekert KA, Borrelli B, Bilderback A & Rand CS (2011) The development of a motivational 
interviewing intervention to promote adherence among inter-city, African American 
adolescents with asthma. Patient Education & Counseling 82, 117-122. 
Rubak S, Sandbaek A, Lauritzen T & Christensen B (2005) Motivational interviewing: A 
systemic review and meta-analysis. British Journal General Practice, 305-312. 
Rueda S, Park-Wyllie LY, Bayoumi A, Tynan A, Antoniou T, Rourke S & Glazier R (2006) 
Patient support and education for promoting adherence to highly active antiretroviral 
therapy for HIV/AIDS. Cochrane Database of Systematic Reviews 3.  
Ruppar TM, Conn VS & Russell CL (2008) Medication adherence interventions for older adults: 
literature review. Research and theory for nursing practice 22, 114-147.  
Solomon DH, Iversen MD, Avorn J, Gleeson T, Brookhart MA, Patrick AR, Rekedal L, Shrank 
WH, Lii J, Losina E & Katz JN (2012) Osteoporosis telephonic intervention to improve 
medication regimen adherence: A large, pragmatic, randomized controlled trial. Archives 
of Internal Medicine 172, 477-483.  
Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M & Decker V (2013) An 
intervention to improve adherence and management of symptoms for patients prescribed 
oral chemotherapy agents: An exploratory study. Cancer Nursing 36, 18-28.  
Spoelstra SL & Given CW (2011) Assessment and measurement of adherence to oral 
antineoplastic agents. In Seminars in Oncology Nursing. Elsevier, pp. 116-132.  
Stewart KE, Olbrisch ME & Bean MK (2010) Back on track: Confronting post-surgical weight 
gain. Bariatric Nursing & Surgical Patient Care 5, 179-185.  
Streeter SB, Schwartzberg L, Husain N & Johnsrud M (2011) Patient and plan characteristics 
affecting abandonment of oral oncolytic prescriptions. Journal of Oncology Practice 7, 
46s-51s.  
27 
Tatrow K & Montgomery GH (2006) Cognitive behavioral therapy techniques for distress and 
pain in breast cancer patients: A meta-analysis. Journal of Behavioral Medicine 29, 17-
27.  
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, 
Grodensky CA, Rosen DL, Yuen AHS, Sista P & Lohr KN (2012a) Medication 
adherence interventions: Comparitive effectiveness. Closing the quality gap: Revisiting 
the state of the science. Agency for Healthcare Research and Quality Evidence Report 
No. 208. 
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, 
Rosen DL, Sista P & Lohr KN (2012b) Interventions to improve adherence to self-
administered medications for chronic diseases in the United States: a systematic review. 
Annals of Internal Medicine 157, 785-795.  
Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, 
Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L & Walters RS (2008) 
NCCN Task Force Report: Oral chemotherapy. Journal of the National Comprehensive 
Cancer Network 6 Suppl 3, S1-14. 
Whittenmore R & Knafl K (2005) The integrative review: updated methodology. Journal of 
Advanced Nursing 52, 546-553. World Health Organization (2003) Adherence to long-
term therapies: evidence for action. 
 
